Child Mortality Estimation: Accelerated Progress in Reducing Global Child Mortality, 1990–2010
Monitoring development indicators has become a central interest of international agencies and countries for tracking progress towards the Millennium Development Goals. In this review, which also provides an introduction to a collection of articles, we describe the methodology used by the United Nations Inter-agency Group for Child Mortality Estimation to track country-specific changes in the key indicator for Millennium Development Goal 4 (MDG 4), the decline of the under-five mortality rate (the probability of dying between birth and age five, also denoted in the literature as U5MR and 5q0). We review how relevant data from civil registration, sample registration, population censuses, and household surveys are compiled and assessed for United Nations member states, and how time series regression models are fitted to all points of acceptable quality to establish the trends in U5MR from which infant and neonatal mortality rates are generally derived. The application of this methodology indicates that, between 1990 and 2010, the global U5MR fell from 88 to 57 deaths per 1,000 live births, and the annual number of under-five deaths fell from 12.0 to 7.6 million. Although the annual rate of reduction in the U5MR accelerated from 1.9% for the period 1990–2000 to 2.5% for the period 2000–2010, it remains well below the 4.4% annual rate of reduction required to achieve the MDG 4 goal of a two-thirds reduction in U5MR from its 1990 value by 2015. Thus, despite progress in reducing child mortality worldwide, and an encouraging increase in the pace of decline over the last two decades, MDG 4 will not be met without greatly increasing efforts to reduce child deaths.
Vyšlo v časopise:
Child Mortality Estimation: Accelerated Progress in Reducing Global Child Mortality, 1990–2010. PLoS Med 9(8): e32767. doi:10.1371/journal.pmed.1001303
Kategorie:
Review
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001303
Souhrn
Monitoring development indicators has become a central interest of international agencies and countries for tracking progress towards the Millennium Development Goals. In this review, which also provides an introduction to a collection of articles, we describe the methodology used by the United Nations Inter-agency Group for Child Mortality Estimation to track country-specific changes in the key indicator for Millennium Development Goal 4 (MDG 4), the decline of the under-five mortality rate (the probability of dying between birth and age five, also denoted in the literature as U5MR and 5q0). We review how relevant data from civil registration, sample registration, population censuses, and household surveys are compiled and assessed for United Nations member states, and how time series regression models are fitted to all points of acceptable quality to establish the trends in U5MR from which infant and neonatal mortality rates are generally derived. The application of this methodology indicates that, between 1990 and 2010, the global U5MR fell from 88 to 57 deaths per 1,000 live births, and the annual number of under-five deaths fell from 12.0 to 7.6 million. Although the annual rate of reduction in the U5MR accelerated from 1.9% for the period 1990–2000 to 2.5% for the period 2000–2010, it remains well below the 4.4% annual rate of reduction required to achieve the MDG 4 goal of a two-thirds reduction in U5MR from its 1990 value by 2015. Thus, despite progress in reducing child mortality worldwide, and an encouraging increase in the pace of decline over the last two decades, MDG 4 will not be met without greatly increasing efforts to reduce child deaths.
Zdroje
1. BoermaJT, MathersC, Abou-ZahrC (2010) WHO and global health monitoring: the way forward. PLoS Med 7: e1000373 doi:10.1371/journal.pmed.1000373.
2. United Nations Inter-agency Group for Child Mortality Estimation (2011) Levels & trends in child mortality: report 2011. New York: United Nations Children's Fund.
3. OestergaardMZ, InoueM, YoshidaS, MahananiWR, GoreFM, et al. (2011) Neonatal mortality levels for 193 countries in 2009 with trends since 1990: a systematic analysis of progress, projections, and priorities. PLoS Med 8: e1001080 doi:10.1371/journal.pmed.1001080.
4. PedersenJ, LiuJ (2012) Child mortality estimation: appropriate time periods for child mortality estimates from full birth histories. PLoS Med 9: e1001289 doi:10.1371/journal.pmed.1001289.
5. Pullum T (2006) An assessment of age and date reporting in the DHS surveys, 1985–2003. DHS Methodological Reports No.5. Calverton (Maryland): MACRO International.
6. GraafmansWC, RichardusJH, MacfarlaneA, RebagliatoM, BlondelB, et al. (2001) Comparability of published perinatal mortality rates in Western Europe: the quantitative impact of differences in gestational age and birthweight criteria. BJOG 108: 1237–1245.
7. World Health Organization (2011) Estimation methods used by the UN Inter-agency Group for Child Mortality Estimation for the round of estimates generated in 2011. Available: http://www.who.int/entity/healthinfo/statistics/UN_IGME_Estimation_Methods_round_2011.pdf. Accessed 3 July 2012.
8. WalkerN, HillK, ZhaoF (2012) Child mortality estimation: methods used to adjust for bias due to AIDS in estimating trends in under-five mortality. PLoS Med 9: e1001298 doi:10.1371/journal.pmed.1001298.
9. SilvaR (2012) Child mortality estimation: consistency of under-five mortality rate estimates using full birth histories and summary birth histories. PLoS Med 9: e1001296 doi:10.1371/journal.pmed.1001296.
10. GuillotM, GerlandP, PelletierF, SaabnehA (2012) Child mortality estimation: a global overview of infant and child mortality age patterns in light of new empirical data. PLoS Med 9: e1001299 doi:10.1371/journal.pmed.1001299.
11. Coale AJ, Demeny P (1983) Regional model life tables and stable population. Princeton: Princeton University Press.
12. CoaleAJ, GuoG (1989) Revised regional model life tables at very low levels of mortality. Popul Index 55: 613–643.
13. United Nations Department of International Economic and Social Affairs (1982) Model life tables for developing countries. New York: United Nations.
14. United Nations Department of International Economic and Social Affairs (1983) Manual X—indirect techniques for demographic estimation. New York: United Nations.
15. United Nations Department of International Economic and Social Affairs (2011) World population prospects: the 2010 revision. New York: United Nations.
16. SawyerCC (2012) Child mortality estimation: estimating sex differences in childhood mortality since the 1970s. PLoS Med 9: e1001287 doi:10.1371/journal.pmed.1001287.
17. LiuL, JohnsonH, CousensS, PerinJ, ScottS, et al. (2012) Global, regional and national causes of child mortality in 2000–2010: an updated systematic analysis. Lancet 379: 2151–2161.
18. LozanoR, WangH, ForemanKJ, RajaratnamJK, NaghaviM, et al. (2011) Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis. Lancet 378: 1139–1165.
19. AlkemaL, YouD (2012) Child mortality estimation: a comparison of UN IGME and IHME estimates of levels and trends in under-five mortality rates and deaths. PLoS Med 9: e1001288 doi:10.1371/journal.pmed.1001288.
20. Brass W (1975) Methods for estimating fertility and mortality from limited and defective data. Chapel Hill (North Carolina): International Program of Laboratories for Population Research.
21. RajaratnamJK, TranLN, LopezAD, MurrayCJL (2010) Measuring under-five mortality: validation of new low cost methods. PLoS Med 7: e1000253 doi:10.1371/journal.pmed.1000253.
22. United Nations Statistics Division (2012) Millennium development indicators: world and regional groupings [database]. Available: http://mdgs.un.org/unsd/mdg/Host.aspx?Content=Data/RegionalGroupings.htm. Accessed 25 July 2012.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2012 Číslo 8
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Nech brouka žít… Ať žije astma!
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
Najčítanejšie v tomto čísle
- Feasibility, Yield, and Cost of Active Tuberculosis Case Finding Linked to a Mobile HIV Service in Cape Town, South Africa: A Cross-sectional Study
- Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients
- Child Mortality Estimation: A Global Overview of Infant and Child Mortality Age Patterns in Light of New Empirical Data
- What Is the Optimal First Line Antiretroviral Therapy in Resource-Limited Settings?